MAPT and Alzheimer disease: Recent in vivo evidence has suggested that co-pathology, in particular vascular pathologies, may exert a strong negative impact on cognition in participants who have less neurofibrillary tau pathology (35); however, these findings are in consideration of the updated biological definition of AD compared to the clinical (7).